Switch to:
More From Other Websites
ETF’s with exposure to CTI BioPharma Corp. : July 20, 2016 Jul 20 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jun 30 2016
ETF’s with exposure to CTI BioPharma Corp. : June 27, 2016 Jun 27 2016
Surging Earnings Estimates Signal Good News for CTI BioPharma (CTIC) Jun 10 2016
Should CTI BioPharma (CTIC) Be On Your Radar Now? Jun 08 2016
Long-Term Follow Up Data For Pacritinib Presented At 2016 ASCO Annual Meeting Jun 07 2016
ETF’s with exposure to CTI BioPharma Corp. : June 3, 2016 Jun 03 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... May 31 2016
ETF’s with exposure to CTI BioPharma Corp. : May 20, 2016 May 20 2016
CTI BioPharma Corp. :CTIC-US: Earnings Analysis: Q1, 2016 By the Numbers May 19 2016
CTI BIOPHARMA CORP Financials May 19 2016
CTI BioPharma Announces Presentations At The American Society Of Clinical Oncology Annual Meeting May 19 2016
CTI BioPharma posts 1Q profit May 10 2016
CTI BioPharma posts 1Q profit May 10 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 10 2016
CTI BioPharma Reports First Quarter 2016 Financial Results May 10 2016
BrainStorm Cell Therapeutics Reports First Quarter 2016 Financial Results And Provides Corporate... May 10 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Apr 29 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Apr 28 2016
Preclinical Data Presented At AACR Indicate Pacritinib's Potential To Eradicate Therapy-Resistant... Apr 20 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK